Import:3H Biomedizin: Unterschied zwischen den Versionen

3H Biomedical was founded in 2004<ref>{{Cite web |url=http://biotjanster.idg.se/guide/company.asp?id=571 |title=Archived copy |access-date=2009-06-24 |archive-url=https://web.archive.org/web/20111007203948/http://biotjanster.idg.se/guide/company.asp?id=571 |archive-date=2011-10-07 |dead-url=yes |df= }}</ref> as a spring off from [[Uppsala University]].<ref>{{Cite web |url=http://www.uu.se/node616 |title=Archived copy |access-date=2009-06-24 |archive-url=https://web.archive.org/web/20090516024528/http://www.uu.se/node616 |archive-date=2009-05-16 |dead-url=yes |df= }}</ref> In the same year 3H Biomedical was awarded with the foundation of innovation of Handelsbanken Uppsala award. The award was presented for commercially interesting research in the field of DNA-based vaccines.{{Citation needed|date=September 2011}} The company started out marketing and selling primary cells, and has since extended its portfolio with cell chips, [[RNA]], [[DNA]], recombinant proteins, [[blood plasma|blood serum and plasma]], [[Vector (molecular biology)|vectors]] for genetic modification and [[Assay|cell-based assays]].<ref>http://yellowpages.scanbalt.org/uppsala/Ups_search.php?company=12875{{Dead link|date=September 2018 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>